Skip to main content

Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide

User login

Username

Password

Reset your password

Type	Lead	score